Business SK bioscience wins patent invalidation case against Moderna
By Diplomacy Journal Lee Kap-soo SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced on April 23 that it has won a final victory in a patent invalidation lawsuit against Moderna, the global developer of mRNA COVID-19 vaccines. SK bioscience filed the nullity suit over the Moderna’s patent on ‘Modified nucleosides, nucleotides, and nucleic acids and uses thereof’ in 2023. This is the only registered patent related to mRNA manufacturing technology in Korea. After nearly two years of review, the Korean Intellectual